These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29378645)

  • 21. Urinary Biomarkers: Alone Are They Enough?
    Molitoris BA
    J Am Soc Nephrol; 2015 Jul; 26(7):1485-8. PubMed ID: 25535304
    [No Abstract]   [Full Text] [Related]  

  • 22. Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.
    Toprak Z; Cebeci E; Helvaci SA; Toprak ID; Kutlu Y; Sakin A; Tukek T
    Int Urol Nephrol; 2017 Jun; 49(6):1041-1047. PubMed ID: 28255639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical adoption of Nephrocheck® in the early detection of acute kidney injury.
    Ilaria G; Kianoush K; Ruxandra B; Francesca M; Mariarosa C; Davide G; Claudio R
    Ann Clin Biochem; 2021 Jan; 58(1):6-15. PubMed ID: 33081495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of urinary TIMP-2 and IGFBP-7: an adequate diagnostic test to predict acute kidney injury after cardiac surgery?
    Wetz AJ; Richardt EM; Wand S; Kunze N; Schotola H; Quintel M; Bräuer A; Moerer O
    Crit Care; 2015 Jan; 19(1):3. PubMed ID: 25560277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) • Insulin-Like Growth Factor-Binding Protein 7 (IGFBP7) Predicts Adverse Outcome in Pediatric Acute Kidney Injury.
    Westhoff JH; Tönshoff B; Waldherr S; Pöschl J; Teufel U; Westhoff TH; Fichtner A
    PLoS One; 2015; 10(11):e0143628. PubMed ID: 26606754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute kidney injury: cell cycle arrest biomarkers win race for AKI diagnosis.
    Endre ZH; Pickering JW
    Nat Rev Nephrol; 2014 Dec; 10(12):683-5. PubMed ID: 25347946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acute kidney injury].
    Bienholz A; Feldkamp T; Kribben A;
    Dtsch Med Wochenschr; 2013 Jun; 138(23):1229-32. PubMed ID: 23720177
    [No Abstract]   [Full Text] [Related]  

  • 28. Novel acute kidney injury biomarkers: their characteristics, utility and concerns.
    Beker BM; Corleto MG; Fieiras C; Musso CG
    Int Urol Nephrol; 2018 Apr; 50(4):705-713. PubMed ID: 29307055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A promising marker in early diagnosis of septic acute kidney injury of critically ill patients: urine insulin like growth factor binding protein-7.
    Aydoğdu M; Boyacı N; Yüksel S; Gürsel G; Sivri AB
    Scand J Clin Lab Invest; 2016 Sep; 76(5):402-10. PubMed ID: 27240440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary TIMP-2 and IGFBP-7 protein levels as early predictors of acute kidney injury after cardiac surgery.
    Shah HH; Zehra SA; Khatri M
    J Card Surg; 2022 Sep; 37(9):2935. PubMed ID: 35726660
    [No Abstract]   [Full Text] [Related]  

  • 31. "Urinary TIMP-2 and IGFBP-7 protein levels as early predictors of acute kidney injury after cardiac surgery".
    Llerena Velastegui J; Vaca Perez P
    J Card Surg; 2022 Oct; 37(10):3444. PubMed ID: 35791629
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessment of cell-cycle arrest biomarkers to predict early and delayed acute kidney injury.
    Bell M; Larsson A; Venge P; Bellomo R; Mårtensson J
    Dis Markers; 2015; 2015():158658. PubMed ID: 25866432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic Value of Urine Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Acute Kidney Injury: A Meta-Analysis.
    Su Y; Gong Z; Wu Y; Tian Y; Liao X
    PLoS One; 2017; 12(1):e0170214. PubMed ID: 28107490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interest of Urinary [TIMP-2] × [IGFBP-7] for Predicting the Occurrence of Acute Kidney Injury After Cardiac Surgery: A Gray Zone Approach.
    Finge T; Bertran S; Roger C; Candela D; Pereira B; Scott C; Muller L; Louart B; Lefrant JY
    Anesth Analg; 2017 Sep; 125(3):762-769. PubMed ID: 28537976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of cardiac surgery-associated acute kidney injury from functional to damage biomarkers.
    Vandenberghe W; De Loor J; Hoste EA
    Curr Opin Anaesthesiol; 2017 Feb; 30(1):66-75. PubMed ID: 27906719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial.
    Meersch M; Schmidt C; Hoffmeier A; Van Aken H; Wempe C; Gerss J; Zarbock A
    Intensive Care Med; 2017 Nov; 43(11):1551-1561. PubMed ID: 28110412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analytical characteristics of a biomarker-based risk assessment test for acute kidney injury (AKI).
    Uettwiller-Geiger DL; Vijayendran R; Kellum JA; Fitzgerald RL
    Clin Chim Acta; 2016 Apr; 455():93-8. PubMed ID: 26797672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk prediction of acute kidney injury by [TIMP-2]•[IGFBP7].
    Kimmel M; Schanz M; Alscher MD
    Drugs Today (Barc); 2017 Jun; 53(6):349-356. PubMed ID: 28799580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Stratification for Acute Kidney Injury: Are Biomarkers Enough?
    McMahon BA; Koyner JL
    Adv Chronic Kidney Dis; 2016 May; 23(3):167-78. PubMed ID: 27113693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers of renal function, which and when?
    Wasung ME; Chawla LS; Madero M
    Clin Chim Acta; 2015 Jan; 438():350-7. PubMed ID: 25195004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.